The rate of administration can be controlled to ensure the patient receives the right amount over a specific period
hsCRP reduction by dose: 5 mg tirzepatide: Mean difference of -20.3 compared to placebo (95% CI: -35.2 to -5.3) 10 mg tirzepatide: Mean difference of -33.9 compared to placebo (95% CI: -50.3 to -17.6) 15 mg tirzepatide: Mean difference of -32.9 compared to placebo (95% CI: -33.6 to -32.2) Notice something
Journal (Journal of Physiology Paris, MayOct 1997, 91(35), 173178)
Avoid high-fat and spicy foods that may exacerbate gastrointestinal symptoms
P., Fouquerel, E., & Opresko, P
If youre evaluating any compounded product, your prescriber (and pharmacist) should be able to explain the specific clinical reason a compounded preparation is needed, and what quality controls are in place